| 38.64 -2.69 (-6.51%) | 03-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 48.83 |
1-year : | 52.4 |
| Resists | First : | 41.81 |
Second : | 44.86 |
| Pivot price | 40.97 |
|||
| Supports | First : | 36.86 |
Second : | 30.67 |
| MAs | MA(5) : | 41 |
MA(20) : | 40.58 |
| MA(100) : | 37.06  |
MA(250) : | 28.21 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 30.8 |
D(3) : | 42.5 |
| RSI | RSI(14): 42.2 |
|||
| 52-week | High : | 44.86 | Low : | 15.48 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ BTSG ] has closed below the lower bollinger band by 15.4%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ BTSG ] is to continue within current trading range. Bollinger Bands are 13.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 41.3 - 41.64 | 41.64 - 41.86 |
| Low: | 37.01 - 37.35 | 37.35 - 37.59 |
| Close: | 38.18 - 38.72 | 38.72 - 39.09 |
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
Fri, 06 Mar 2026
Brightspring Health’s Nalley sells $1.23 million in BTSG stock By Investing.com - Investing.com Canada
Fri, 06 Mar 2026
Latham Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase - Legal Desire Media and Insights
Mon, 02 Mar 2026
BrightSpring Health Services Announces Pricing of 20 Million Share Secondary Offering at $41.15 per Share - Quiver Quantitative
Mon, 02 Mar 2026
Cowen Maintains Buy on BTSG BrightSpring Health Services, Inc. Common Stock Mar 2026 - Meyka
Mon, 02 Mar 2026
BrightSpring prices secondary offering of 20 million shares of common stock at $41.15 per share - marketscreener.com
Mon, 02 Mar 2026
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 194 (M) |
| Shares Float | 161 (M) |
| Held by Insiders | 3 (%) |
| Held by Institutions | 100.3 (%) |
| Shares Short | 7,670 (K) |
| Shares Short P.Month | 7,860 (K) |
| EPS | 0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 9.19 |
| Profit Margin | 1.4 % |
| Operating Margin | 3 % |
| Return on Assets (ttm) | 3.2 % |
| Return on Equity (ttm) | 5.9 % |
| Qtrly Rev. Growth | 29.2 % |
| Gross Profit (p.s.) | 7.85 |
| Sales Per Share | 66.7 |
| EBITDA (p.s.) | 2.5 |
| Qtrly Earnings Growth | 338.2 % |
| Operating Cash Flow | 490 (M) |
| Levered Free Cash Flow | -335 (M) |
| PE Ratio | 80.5 |
| PEG Ratio | 0 |
| Price to Book value | 4.19 |
| Price to Sales | 0.57 |
| Price to Cash Flow | 15.25 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|